RHEA Generics, Bayer Philippines Unites for Stroke-Prevention Medication
In a milestone move that promises to transform healthcare accessibility in the Philippines, PHILUSA Corporation forged a partnership with Bayer Philippines to bring forth a new era of world-class quality medicines at affordable prices through RHEA Generics.
On February 5, 2024, Neogin Evangelista, President and General Manager of PHILUSA Corporation, Angel Michaelo Evangelista, Managing Director and Country Division Head of Bayer Philippines, and Corazon Lim, Vice President for Merchandising of Mercury Drug Corporation, led the ceremonial signing event at the Bayer Philippines Head Office.
This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of PHILUSA Corporation’s global pharmaceutical partners. Together, these industry giants aim to provide Filipino patients with an effective product for the prevention of stroke and treatment of thromboembolic events. “We’re here to help Filipino patients in accessing affordable generic medicines while ensuring their quality, safety, and efficacy,” said Mr. Neogin Evangelista.
World Class Medicine
The Philippines, also with its diverse demographic and varying lifestyle patterns, is witnessing an increase in cases of stroke. The Department of Health (DOH) reports that stroke ranks among the top three leading causes of death in the country, affecting both urban and rural populations. Mr. Angel Michaelo Evangelista shared that there are more than half a million patients affected by this disease, and the partnership aims to redefine the standards of healthcare affordability and availability.
“Our mission is health for all. We are committed to ensuring that stroke-prevention medicine is available through our partner, RHEA Generics. This will provide enhanced patient access to high-quality and affordable medicine.” The wide distribution reach of Mercury Drug is also instrumental in making public health within reach. Ms. Corazon Lim stated, “Our customers are assured of availability, affordability, and accessibility.”’
Furthermore, launched in 2014, RHEA Generics offers a range of innovative generic medicines developed in partnership with global pharmaceutical leaders, including Pfizer, Viatris, Sanofi, GSK, Otsuka, Merck, Fresenius Kabi, OEP Philippines, Lundbeck, Boehringer Ingelheim, and AstraZeneca. Moreover, its portfolio of medicines includes treatments for hypertension, diabetes, hypercholesterolemia, respiratory infections, and chronic kidney disease, among others.
RHEA Generics are available at Mercury Drug Store branches nationwide. RHEA Generics products is a homegrown brand of PHILUSA Corporation and a pioneer in the generics industry with more than 40 years of experience in producing world-class quality and affordable healthcare products.
For more information and updates, follow the social media pages RHEA Generics PH on Facebook and rheagenericsph on Instagram.
